![Alan Musso](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alan Musso
Directeur Financier/CFO chez
FULCRUM THERAPEUTICS, INC.
Fortune : - $ au 31/05/2026
Profil
Mr. Alan A. Musso, CPA, is an Independent Director at Rein Therapeutics, Inc., a Chief Financial Officer & Treasurer at Fulcrum Therapeutics, Inc. and an Independent Director at Research Alliance Corp.
IV.
He is on the Board of Directors at Rein Therapeutics, Inc. and Research Alliance Corp.
IV.
Mr. Musso was previously employed as a Chief Financial & Accounting Officer by OS Therapies, Inc., a Chief Financial Officer by ReViral Ltd., a Chief Financial Officer by Peloton Therapeutics, Inc., a Chief Financial Officer & Treasurer by Bellicum Pharmaceuticals, Inc., a CFO, Treasurer, SVP-Finance & Administration by Targacept, Inc., a Chief Financial Officer by Cato Research LLC, a Chief Financial Officer & Vice President by Osiris Therapeutics, Inc., a Senior Internal Auditor by Pfizer Inc., a Chief Financial Officer & Treasurer by Teva Women's Health, Inc., and a Chief Financial Officer by Vascular Genetics, Inc. He also served on the board at Lung Therapeutics LLC.
He received his undergraduate degree from St. Mary's College of California and a graduate degree from Thunderbird School of Global Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 13/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Alan Musso
| Sociétés | Poste | Début |
|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Directeur Financier/CFO | 07/08/2023 |
| REIN THERAPEUTICS INC. | Directeur/Membre du Conseil | 31/10/2023 |
Anciens postes connus de Alan Musso
| Sociétés | Poste | Fin |
|---|---|---|
Lung Therapeutics LLC
 Lung Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel pipeline of first-in-class medicines for fibrosis | Directeur/Membre du Conseil | 31/10/2023 |
| OS THERAPIES INCORPORATED | Directeur Financier/CFO | 30/06/2023 |
ReViral Ltd.
 ReViral Ltd. BiotechnologyHealth Technology Develops novel antiviral therapeutics | Directeur Financier/CFO | 01/09/2022 |
| PELOTON THERAPEUTICS, INC. | Directeur Financier/CFO | 01/09/2019 |
| BELLICUM PHARMACEUTICALS, INC. | Directeur Financier/CFO | 31/08/2018 |
Formation de Alan Musso
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
51
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Teva Women's Health, Inc.
 Teva Women's Health, Inc. Pharmaceuticals: MajorHealth Technology Provides women's healthcare products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Researches and develops therapeutic products for the regeneration of human connective tissues | Health Technology |
Thunderbird School of Global Management
 Thunderbird School of Global Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer | Health Technology |
Rein Therapeutics, Inc.
 Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs | Health Technology |
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
Lung Therapeutics LLC
Lung Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel pipeline of first-in-class medicines for fibrosis | Health Technology |
Vascular Genetics, Inc.
 Vascular Genetics, Inc. Medical SpecialtiesHealth Technology Develops pharmaceutical products used in gene therapy | Health Technology |
Cato Research LLC
 Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Specializes in drug development support services for clients in the pharmaceutical, biotechnology and medical device industries | Commercial Services |
Targacept, Inc.
 Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | Health Technology |
St. Mary's College of California
 St. Mary's College of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ReViral Ltd.
ReViral Ltd. BiotechnologyHealth Technology Develops novel antiviral therapeutics | Health Technology |
Fulcrum Therapeutics, Inc.
 Fulcrum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for patients by transforming gene regulation in disease | Health Technology |
OS Therapies, Inc.
 OS Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical stage therapeutic company engages in development and commercialization of treatments for osteosarcoma | Health Technology |
